Contact
searchSearch
HMP Global

Volume 26 - Issue 12 - December 2018

Popular Articles

Amy McMichael, MD
Videos
Insights From Fall Clinical: Alopecia Areata in Skin of Color and JAK Inhibitors
10/19/2023
Amy J. McMichael, MD
In this feature video, Dr Amy McMichael shares what will be presented during her session, “What You Need To Know NOW About Hair Loss in Skin of Color.”
In this feature video, Dr Amy McMichael shares what will be presented during her session, “What You Need To Know NOW About Hair Loss in Skin of Color.”
In this feature video, Dr Amy...
10/19/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
Neal Bhatia, MD
Videos
Insights From 2024 Winter Clinical Hawaii: What's New and Hot in AK Management
01/12/2024
Neal K. Bhatia, MD
In this feature video, Dr Neal Bhatia shares insights into his session, “What's New and Hot in AK Management."
In this feature video, Dr Neal Bhatia shares insights into his session, “What's New and Hot in AK Management."
In this feature video, Dr Neal...
01/12/2024
The Dermatologist
psoriasis
News
Psoriasis and Peroxisome Proliferator-Activated Receptor Pathway Regulation
02/23/2024
Jessica Garlewicz
Researchers established a psoriasis-like keratinocytes model by stimulating HaCaT cells with a cytokine cocktail.
Researchers established a psoriasis-like keratinocytes model by stimulating HaCaT cells with a cytokine cocktail.
Researchers established a...
02/23/2024
The Dermatologist
psoriasis
News
Molecular Commonalities Between Psoriasis and Obesity
04/11/2024
Jessica Garlewicz
Researchers aimed to explore the common inflammatory mechanisms underlying the high comorbidity between psoriasis and obesity.
Researchers aimed to explore the common inflammatory mechanisms underlying the high comorbidity between psoriasis and obesity.
Researchers aimed to explore the...
04/11/2024
The Dermatologist

Subscribe

The Dermatologist Newsletter
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive

Latest Quizzes and Trivia

acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist

December 2018 Volume 26 Issue 12

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use